Intra-Cellular Therapies Statistics
Total Valuation
ITCI has a market cap or net worth of $13.66 billion. The enterprise value is $12.68 billion.
Important Dates
The last earnings date was Friday, February 21, 2025, before market open.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITCI has 106.24 million shares outstanding. The number of shares has increased by 7.56% in one year.
| Current Share Class | 106.24M |
| Shares Outstanding | 106.24M |
| Shares Change (YoY) | +7.56% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 95.97% |
| Float | 104.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 182.52 |
| PS Ratio | 19.48 |
| Forward PS | 15.73 |
| PB Ratio | 11.90 |
| P/TBV Ratio | 11.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.36 |
| Quick Ratio | 5.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.58% and return on invested capital (ROIC) is -8.23%.
| Return on Equity (ROE) | -8.58% |
| Return on Assets (ROA) | -6.96% |
| Return on Invested Capital (ROIC) | -8.23% |
| Return on Capital Employed (ROCE) | -10.05% |
| Revenue Per Employee | $1.12M |
| Profits Per Employee | -$122,420 |
| Employee Count | 610 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 3.00 |
Taxes
In the past 12 months, ITCI has paid $473,000 in taxes.
| Income Tax | 473,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.49% in the last 52 weeks. The beta is 0.72, so ITCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +74.49% |
| 50-Day Moving Average | 108.53 |
| 200-Day Moving Average | 83.75 |
| Relative Strength Index (RSI) | 83.90 |
| Average Volume (20 Days) | 2,212,674 |
Short Selling Information
The latest short interest is 1.60 million, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 1.50M |
| Short % of Shares Out | 1.51% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, ITCI had revenue of $680.85 million and -$74.68 million in losses. Loss per share was -$0.72.
| Revenue | 680.85M |
| Gross Profit | 623.89M |
| Operating Income | -116.72M |
| Pretax Income | -83.40M |
| Net Income | -74.68M |
| EBITDA | -116.19M |
| EBIT | -116.72M |
| Loss Per Share | -$0.72 |
Full Income StatementBalance Sheet
The company has $1.00 billion in cash and $16.98 million in debt, giving a net cash position of $984.09 million or $9.26 per share.
| Cash & Cash Equivalents | 1.00B |
| Total Debt | 16.98M |
| Net Cash | 984.09M |
| Net Cash Per Share | $9.26 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 10.81 |
| Working Capital | 1.10B |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 91.63%, with operating and profit margins of -17.14% and -10.97%.
| Gross Margin | 91.63% |
| Operating Margin | -17.14% |
| Pretax Margin | -10.90% |
| Profit Margin | -10.97% |
| EBITDA Margin | -17.07% |
| EBIT Margin | -17.14% |
| FCF Margin | n/a |